Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The re-emergence of dengue virus as a significant human pathogen has lead to an increasing need for effective antivirals. Development of therapeutic agents with the ability to attenuate both the duration and severity of disease in patients after infection is particularly desirable in dengue endemic resource-poor settings. The reliance of dengue virus on endogenous processes during the late stages of infection prompts the development of molecules to interfere with and exploit these dependencies as potential antiviral therapies. Here we focus on the importance of N-linked glycan processing in infectious virion morphogenesis.

Original publication




Journal article


Trends Microbiol

Publication Date





323 - 330


Animals, Antiviral Agents, Cell Line, Cricetinae, Dengue, Dengue Virus, Enzyme Inhibitors, Glycosylation, Host-Pathogen Interactions, Humans, Inhibitory Concentration 50, Models, Biological, Protein Processing, Post-Translational, Viral Proteins